Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

NCT05037461 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumor of Pancreas
Multiple Endocrine Neoplasia Type 1

Interventions

RADIATION: High-dose-high precision MR-guided radiotherapy

Sponsor

J.M. de Laat

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]